Harbour Investments »

Cyclacel Pharmaceuticals shares owned by Harbour Investments

Quarter-by-quarter ownership of Cyclacel Pharmaceuticals (CYCC) shares owned by Harbour Investments from 13F filings

Historical chart of Harbour Investments investment in Cyclacel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Cyclacel Pharmaceuticals held by Harbour Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyclacel Pharmaceuticals by Harbour Investments

Quarter filed Position value Share count Share price at filing
2024-09-30 $13 13 1.00
2024-06-30 $21 13 1.62
2024-03-31 $26 13 2.08
2023-12-31 $34 13 2.69

More positions owned by Harbour Investments

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Pacer Fds Tr Pacer Us Small (CALF)
First Tr Exchng Traded Fd Vi Tcw Unconstrai (UCON)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Apple (AAPL)
Ishares Tr Core S&p Mcp Etf (IJH)
First Tr Exchng Traded Fd Vi Ft Vest Laddered (BUFR)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Capital Grp Fixed Incm Etf T Core Plus Incm (CGCP)

View all positions for Harbour Investments

Top funds holding Cyclacel Pharmaceuticals

Armistice Capital
Point72 Asset Management
Acadian Asset Management
Geode Capital Management
Tower Research Capital
McIlrath & Eck
Activest Wealth Management
Advisor Group Holdings
Morgan Stanley
Wells Fargo & Company
Signature
Bank of America Corporation
Harbour Investments
Qube Research & Technologies

View all funds holding Cyclacel Pharmaceuticals